Schedule 13D ownership disclosure

Tracon Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 89237H100

Event date: 2018-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,601,768
Percent of class
15.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001733439-18-000008
Form type
SC 13D
Filer
Puissance Cross-Border Opportunities V LLC
CIK
CIK 1733439
Filed
Apr 06, 2018
Reporting period
Mar 27, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub